Clinical Trial Update: A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, immunogenicity, and efficacy of PvRII/Matrix-M malaria vaccine in healthy Thai adults, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Matrix-M (Matrix-M adjuvant)
• PvRII

Snippet

Sponsor: University of Oxford | Conditions: Plasmodium Vivax Infection, Malaria Vaccine | Phase 2 | Status: NOT_YET_RECRUITING